Cabergoline (Teva Pharmaceuticals USA Inc)
Welcome to the PulseAid listing for the Cabergoline drug offered from Teva Pharmaceuticals USA Inc. This Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA Inc |
NON-PROPRIETARY NAME: | Cabergoline |
SUBSTANCE NAME: | CABERGOLINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2007-03-07 |
END MARKETING DATE: | 0000-00-00 |
Cabergoline HUMAN PRESCRIPTION DRUG Details:
Item Description | Cabergoline from Teva Pharmaceuticals USA Inc |
LABELER NAME: | Teva Pharmaceuticals USA Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/1) |
START MARKETING DATE: | 2007-03-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0093-5420_bd7797e1-c1b4-43ef-8e1f-bbbd76da0a63 |
PRODUCT NDC: | 0093-5420 |
APPLICATION NUMBER: | ANDA077750 |
Other CABERGOLINE Pharmaceutical Manufacturers / Labelers: